Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,020 | -40,312 | -33,589 | -26,230 | -166,577 |
| Depreciation Amortization | 78,015 | 58,478 | 39,409 | 19,244 | 54,897 |
| Income taxes - deferred | N/A | 5,066 | 5,111 | N/A | N/A |
| Accounts receivable | 4,301 | 2,637 | -753 | -2,133 | -21,626 |
| Accounts payable and accrued liabilities | 10,750 | 2,843 | 5,083 | 6,075 | -4,029 |
| Other Working Capital | 30,824 | 32,710 | 19,357 | 3,081 | 29,765 |
| Other Operating Activity | 84,900 | 14,894 | 8,521 | 2,342 | 139,120 |
| Operating Cash Flow | $78,770 | $76,316 | $43,139 | $2,379 | $31,550 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -67,865 | -60,208 | -73,902 | 147,060 |
| PPE Investments | -36,249 | -26,823 | -16,877 | -9,449 | -41,268 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -432,558 |
| Purchase Of Investment | -384,206 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 308,759 | 6,829 | 3,391 | 3,414 | 6,876 |
| Purchase Sale Intangibles | -16,027 | -15,662 | 2,750 | 2,750 | -873 |
| Other Investing Activity | -4,296 | 11,069 | 32,750 | 2,750 | -873 |
| Investing Cash Flow | $-115,992 | $-76,790 | $-40,944 | $-77,187 | $-320,763 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 242,048 |
| Debt Repayment | -675 | -291 | -116 | -169 | -721 |
| Common Stock Issued | 33,529 | 22,521 | 20,298 | 15,803 | 139,868 |
| Financing Cash Flow | $32,854 | $22,230 | $20,182 | $15,634 | $381,195 |
| Beginning Cash Position | 183,377 | 183,377 | 183,377 | 183,377 | 91,395 |
| End Cash Position | 179,009 | 205,133 | 205,754 | 124,203 | 183,377 |
| Net Cash Flow | $-4,368 | $21,756 | $22,377 | $-59,174 | $91,982 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78,770 | 76,316 | 43,139 | 2,379 | 31,550 |
| Capital Expenditure | -36,518 | -26,932 | -16,877 | -9,449 | -41,268 |
| Free Cash Flow | 42,252 | 49,384 | 26,262 | -7,070 | -9,718 |